Translational CNS medicines research

Drug Discovery Today
Alan M Palmer, Mohammad S Alavijeh

Abstract

The major imperative of the pharmaceutical industry is to effectively translate insights gained from basic research into new medicines. This task is toughest for CNS disorders. Compared with non-CNS drugs, CNS drugs take longer to get to market and their attrition rate is greater. This is principally because of the complexity of the human brain (the cause of many brain disorders remains unknown), the liability of CNS drugs to cause CNS side effects (which limits their use) and the requirement of CNS medicines to cross the blood-CNS barrier (BCNSB) (which restricts their ability to interact with their CNS target). In this review we consider the factors that are important in translating neuroscience research into CNS medicines.

References

Oct 1, 1994·Journal of Neurology, Neurosurgery, and Psychiatry·C S AndersonK D Jamrozik
Feb 20, 1997·The New England Journal of Medicine·D W MarionS T DeKosky
Sep 14, 2001·European Journal of Drug Metabolism and Pharmacokinetics·M R FengT Su
Aug 17, 2002·Methods : a Companion to Methods in Enzymology·Jan PasschierAren van Waarde
Nov 20, 2002·The Journal of Pharmacology and Experimental Therapeutics·Kelly M Mahar DoanJoseph W Polli
Feb 26, 2004·Free Radical Biology & Medicine·Kuresh A YoudimN Joan Abbott
Mar 16, 2004·Lancet·Werner HackeUNKNOWN NINDS rt-PA Study Group Investigators
Dec 21, 2004·Psychopharmacology·Benoit Petit-DemouliereMichel Bourin
Dec 29, 2004·International Journal of Pharmaceutics·Qing WangIsmael J Hidalgo
Dec 31, 2005·Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging·Daniel Goldberg-ZimringSimon K Warfield
Feb 14, 2006·Current Drug Metabolism·Andreas Reichel
Feb 21, 2006·NeuroRx : the Journal of the American Society for Experimental NeuroTherapeutics·Hassan Pajouhesh, George R Lenz
Feb 21, 2006·NeuroRx : the Journal of the American Society for Experimental NeuroTherapeutics·Mohammad S AlavijehAlan M Palmer
May 2, 2006·Journal of Magnetic Resonance Imaging : JMRI·Peter Jezzard, Richard B Buxton
Jun 27, 2007·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Markus FridénMargareta Hammarlund-Udenaes
Jun 30, 2007·Nature Reviews. Drug Discovery·Menelas N PangalosOrest Hurko
Aug 24, 2007·Expert Opinion on Investigational Drugs·Zhengming Chen, Phil Skolnick
Nov 29, 2007·Pharmacotherapy·Hubert H Fernandez, Jack J Chen
Feb 20, 2008·Progress in Neurobiology·Bradley J Turner, Kevin Talbot
Mar 4, 2008·Journal of Internal Medicine·W P T James
Mar 29, 2008·Stroke; a Journal of Cerebral Circulation·Hans-Christoph DienerUNKNOWN SAINT I and II Investigators
Apr 15, 2008·Drug Discovery Today·Gerhard F EckerPeter Chiba
Apr 16, 2008·The Journal of General Physiology·Gregory J KaczorowskiMaria L Garcia
Nov 4, 2008·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·S G SummerfieldA D Ruffo
Feb 25, 2009·The International Journal of Neuropsychopharmacology·Takeaki SaijoTetsuya Suhara
May 12, 2009·Neuroscience and Biobehavioral Reviews·Florent G RevelJean-Luc Moreau
Aug 12, 2009·Neurobiology of Disease·Alan M Palmer
Oct 13, 2009·Neurobiology of Disease·Mohammad S Alavijeh, Alan M Palmer
Dec 31, 2009·JAMA : the Journal of the American Medical Association·Beth E SnitzUNKNOWN Ginkgo Evaluation of Memory (GEM) Study Investigators
Mar 2, 2010·Expert Review of Neurotherapeutics·Anna P AndreouPeter J Goadsby
Mar 17, 2010·Pflügers Archiv : European journal of physiology·Anthony Lau, Michael Tymianski
May 21, 2010·Expert Opinion on Pharmacotherapy·Tanvir U Syed, Martha Sajatovic
Jun 29, 2010·Journal of Chemical Information and Modeling·Yi FanChristine Humblet
Aug 4, 2010·Drug Discovery Today·John DixonAlan Palmer
Sep 28, 2010·Central Nervous System Agents in Medicinal Chemistry·Carmen RubioCarlos Paz
Oct 12, 2010·CNS Drugs·Santiago Perez-Lloret, Olivier Rascol
Oct 13, 2010·Biochemical Pharmacology·Steven C LeiserDavid M Devilbiss
Dec 24, 2010·British Journal of Pharmacology·Niklas Marklund, Lars Hillered
Jan 25, 2011·Trends in Pharmacological Sciences·Alan M Palmer
Jan 29, 2011·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Carlos Leiva-SalinasChelsea S Kidwell

❮ Previous
Next ❯

Citations

Feb 13, 2013·Cardiovascular Psychiatry and Neurology·Alan M Palmer
Feb 6, 2016·Journal of Medicinal Chemistry·Sunting XuanM Graça H Vicente
Apr 5, 2013·Expert Opinion on Drug Delivery·Medha PatelKamalinder K Singh
Mar 5, 2013·Drug Discovery Today·Alan M Palmer, Lars Sundstrom
Jun 19, 2015·Journal of Controlled Release : Official Journal of the Controlled Release Society·Alice GaudinPatrick Couvreur
Apr 9, 2016·Journal of Pharmacological and Toxicological Methods·Michael V AccardiSimon Authier
Dec 3, 2013·Drug Discovery Today·Alan M Palmer
Jun 7, 2016·Journal of Pharmacological and Toxicological Methods·Simon AuthierMichael J Curtis
Jan 23, 2014·Molecular Pharmaceutics·Kathryn BallXavier Declèves
Dec 13, 2016·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Pavlina MarvanovaPetr Mokry
Feb 10, 2018·Materials·Rémy PoupotSéverine Fruchon
Nov 25, 2014·Nature Nanotechnology·Alice GaudinPatrick Couvreur
Dec 3, 2014·Pharmaceutical Research·David J Mc CarthyCaitriona M O'Driscoll
Feb 11, 2014·Current Protocols in Pharmacology·Alan M Palmer, Mohammad S Alavijeh
Sep 12, 2017·Nihon yakurigaku zasshi. Folia pharmacologica Japonica·Mariko Takeda
Feb 23, 2020·Acta Pharmaceutica Sinica. B·Yang WangHaopeng Sun

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute Stroke

A stroke occurs when blood supply to the brain is interrupted depriving the brain of oxygen and nutrients. This feed focuses cerebrovascular accidents including ischemic and paralytic stroke.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Astrocytes in Parkinson Disease

Parkinson's disease (PD) is a neurodegenerative disorder caused by the progressive loss of dopaminergic neurons. Some PD-genes may be associated with astrocyte dysfunction. Discover the latest research on astrocytes in Parkinson's disease here.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.

Astrocytes & Amyloid

Astrocytes are thought to play a role in amyloid production and have been implicated in neurodegenerative diseases such as Alzheimer’s disease. Here is the latest research on the relationship between astrocytes and amyloid.

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.

Alzheimer's Disease: Neuroimaging

Neuroimaging can help identify pathological hallmarks of Alzheimer's disease (AD). Here is the latest research on neuroimaging modalities, including magnetic resonance imaging and positron emission tomography, in AD.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.

Astrocytes & Neurodegeneration

Astrocytes are important for the health and function of the central nervous system. When these cells stop functioning properly, either through gain of function or loss of homeostatic controls, neurodegenerative diseases can occur. Here is the latest research on astrocytes and neurodegeneration.

Brain Injury & Trauma

brain injury after impact to the head is due to both immediate mechanical effects and delayed responses of neural tissues.

Cell Adhesion Molecules in the Brain

Cell adhesion molecules found on cell surface help cells bind with other cells or the extracellular matrix to maintain structure and function. Here is the latest research on their role in the brain.